Selected research
Industry Research
Primidone Industry Research Report 2026
Market perspective
The global Primidone market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Primidone is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Primidone is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Primidone is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Primidone include Amneal Pharm, Anda Repository, Dr Reddys Laboratories, Hikma Intl Pharms, Impax Laboratories, Lannett, Mutual Pharmaceutical, Oxford Pharms and Valeant, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Primidone market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Primidone Market by Company
Amneal Pharm
Anda Repository
Dr Reddys Laboratories
Hikma Intl Pharms
Impax Laboratories
Lannett
Mutual Pharmaceutical
Oxford Pharms
Valeant
Valeant Pharmaceuticals International
Vintage Pharmaceuticals
Watson Labs
West Ward Pharmaceutical
Xcel Pharmaceuticals
Primidone Segment by Type
50mg
250mg
Primidone Segment by Application
Epilepsy
Psychiatric Disorders
Essential Tremor
Primidone Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Primidone market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Primidone and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Primidone.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Primidone manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Primidone by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Primidone in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 50mg
- 250mg
Applications
- Epilepsy
- Psychiatric Disorders
- Essential Tremor
Companies covered
- Amneal Pharm
- Anda Repository
- Dr Reddys Laboratories
- Hikma Intl Pharms
- Impax Laboratories
- Lannett
- Mutual Pharmaceutical
- Oxford Pharms
- Valeant
- Valeant Pharmaceuticals International
- Vintage Pharmaceuticals
- Watson Labs
- West Ward Pharmaceutical
- Xcel Pharmaceuticals
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Primidone Market Size (2021-2032)
- 2.2.2 Global Primidone Sales (2021-2032)
- 2.2.3 Global Primidone Market Average Price (2021-2032)
- 2.3 Primidone by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 50mg
- 2.3.3 250mg
- 2.4 Primidone by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Epilepsy
- 2.4.3 Psychiatric Disorders
- 2.4.4 Essential Tremor
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Primidone Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Primidone Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Primidone Revenue of Manufacturers (2021-2026)
- 3.4 Global Primidone Average Price by Manufacturers (2021-2026)
- 3.5 Global Primidone Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Primidone, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Primidone, Product Type & Application
- 3.8 Global Manufacturers of Primidone, Established Date
- 3.9 Global Primidone Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Amneal Pharm
- 4.1.1 Amneal Pharm Company Information
- 4.1.2 Amneal Pharm Business Overview
- 4.1.3 Amneal Pharm Primidone Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Amneal Pharm Primidone Product Portfolio
- 4.1.5 Amneal Pharm Recent Developments
- 4.2 Anda Repository
- 4.2.1 Anda Repository Company Information
- 4.2.2 Anda Repository Business Overview
- 4.2.3 Anda Repository Primidone Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Anda Repository Primidone Product Portfolio
- 4.2.5 Anda Repository Recent Developments
- 4.3 Dr Reddys Laboratories
- 4.3.1 Dr Reddys Laboratories Company Information
- 4.3.2 Dr Reddys Laboratories Business Overview
- 4.3.3 Dr Reddys Laboratories Primidone Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Dr Reddys Laboratories Primidone Product Portfolio
- 4.3.5 Dr Reddys Laboratories Recent Developments
- 4.4 Hikma Intl Pharms
- 4.4.1 Hikma Intl Pharms Company Information
- 4.4.2 Hikma Intl Pharms Business Overview
- 4.4.3 Hikma Intl Pharms Primidone Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Hikma Intl Pharms Primidone Product Portfolio
- 4.4.5 Hikma Intl Pharms Recent Developments
- 4.5 Impax Laboratories
- 4.5.1 Impax Laboratories Company Information
- 4.5.2 Impax Laboratories Business Overview
- 4.5.3 Impax Laboratories Primidone Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Impax Laboratories Primidone Product Portfolio
- 4.5.5 Impax Laboratories Recent Developments
- 4.6 Lannett
- 4.6.1 Lannett Company Information
- 4.6.2 Lannett Business Overview
- 4.6.3 Lannett Primidone Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Lannett Primidone Product Portfolio
- 4.6.5 Lannett Recent Developments
- 4.7 Mutual Pharmaceutical
- 4.7.1 Mutual Pharmaceutical Company Information
- 4.7.2 Mutual Pharmaceutical Business Overview
- 4.7.3 Mutual Pharmaceutical Primidone Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Mutual Pharmaceutical Primidone Product Portfolio
- 4.7.5 Mutual Pharmaceutical Recent Developments
- 4.8 Oxford Pharms
- 4.8.1 Oxford Pharms Company Information
- 4.8.2 Oxford Pharms Business Overview
- 4.8.3 Oxford Pharms Primidone Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Oxford Pharms Primidone Product Portfolio
- 4.8.5 Oxford Pharms Recent Developments
- 4.9 Valeant
- 4.9.1 Valeant Company Information
- 4.9.2 Valeant Business Overview
- 4.9.3 Valeant Primidone Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Valeant Primidone Product Portfolio
- 4.9.5 Valeant Recent Developments
- 4.10 Valeant Pharmaceuticals International
- 4.10.1 Valeant Pharmaceuticals International Company Information
- 4.10.2 Valeant Pharmaceuticals International Business Overview
- 4.10.3 Valeant Pharmaceuticals International Primidone Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Valeant Pharmaceuticals International Primidone Product Portfolio
- 4.10.5 Valeant Pharmaceuticals International Recent Developments
- 4.11 Vintage Pharmaceuticals
- 4.11.1 Vintage Pharmaceuticals Company Information
- 4.11.2 Vintage Pharmaceuticals Business Overview
- 4.11.3 Vintage Pharmaceuticals Primidone Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Vintage Pharmaceuticals Primidone Product Portfolio
- 4.11.5 Vintage Pharmaceuticals Recent Developments
- 4.12 Watson Labs
- 4.12.1 Watson Labs Company Information
- 4.12.2 Watson Labs Business Overview
- 4.12.3 Watson Labs Primidone Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Watson Labs Primidone Product Portfolio
- 4.12.5 Watson Labs Recent Developments
- 4.13 West Ward Pharmaceutical
- 4.13.1 West Ward Pharmaceutical Company Information
- 4.13.2 West Ward Pharmaceutical Business Overview
- 4.13.3 West Ward Pharmaceutical Primidone Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 West Ward Pharmaceutical Primidone Product Portfolio
- 4.13.5 West Ward Pharmaceutical Recent Developments
- 4.14 Xcel Pharmaceuticals
- 4.14.1 Xcel Pharmaceuticals Company Information
- 4.14.2 Xcel Pharmaceuticals Business Overview
- 4.14.3 Xcel Pharmaceuticals Primidone Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Xcel Pharmaceuticals Primidone Product Portfolio
- 4.14.5 Xcel Pharmaceuticals Recent Developments
5 Global Primidone Market Scenario by Region
- 5.1 Global Primidone Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Primidone Sales by Region: 2021-2032
- 5.2.1 Global Primidone Sales by Region: 2021-2026
- 5.2.2 Global Primidone Sales by Region: 2027-2032
- 5.3 Global Primidone Revenue by Region: 2021-2032
- 5.3.1 Global Primidone Revenue by Region: 2021-2026
- 5.3.2 Global Primidone Revenue by Region: 2027-2032
- 5.4 North America Primidone Market Facts & Figures by Country
- 5.4.1 North America Primidone Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Primidone Sales by Country (2021-2032)
- 5.4.3 North America Primidone Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Primidone Market Facts & Figures by Country
- 5.5.1 Europe Primidone Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Primidone Sales by Country (2021-2032)
- 5.5.3 Europe Primidone Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Primidone Market Facts & Figures by Country
- 5.6.1 Asia Pacific Primidone Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Primidone Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Primidone Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Primidone Market Facts & Figures by Country
- 5.7.1 South America Primidone Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Primidone Sales by Country (2021-2032)
- 5.7.3 South America Primidone Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Primidone Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Primidone Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Primidone Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Primidone Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Primidone Sales by Type (2021-2032)
- 6.1.1 Global Primidone Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Primidone Sales Market Share by Type (2021-2032)
- 6.2 Global Primidone Revenue by Type (2021-2032)
- 6.2.1 Global Primidone Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Primidone Revenue Market Share by Type (2021-2032)
- 6.3 Global Primidone Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Primidone Sales by Application (2021-2032)
- 7.1.1 Global Primidone Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Primidone Sales Market Share by Application (2021-2032)
- 7.2 Global Primidone Revenue by Application (2021-2032)
- 7.2.1 Global Primidone Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Primidone Revenue Market Share by Application (2021-2032)
- 7.3 Global Primidone Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Primidone Value Chain Analysis
- 8.1.1 Primidone Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Primidone Production Mode & Process
- 8.2 Primidone Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Primidone Distributors
- 8.2.3 Primidone Customers
9 Global Primidone Analyzing Market Dynamics
- 9.1 Primidone Industry Trends
- 9.2 Primidone Industry Drivers
- 9.3 Primidone Industry Opportunities and Challenges
- 9.4 Primidone Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst